And here come the misleading BALCO/Canseco/Bonds connections

17 Comments

Yesterday I anticipated that, in the interests of narrative over information, some writers would probably try to turn the Melky Cabrera and Bartolo Colon PED suspensions into some larger story about Bay Area drug corruption with callbacks to the days of BALCO, Canseco and Bonds.

And I was not disappointed. John Shea:

The steroid cloud that once hovered over Jose Canseco, Mark McGwire and Jason Giambi and Co. in Oakland, and Barry Bonds and his BALCO brethren in San Francisco, is back by the bay.

Bruce Jenkins:

First we had the steroid-enhanced A’s of the late ’80s and early ’90s, led by Jose Canseco and Mark McGwire. Then came the BALCO scandal, with Barry Bonds and several lesser Giants as the central figures. The 2007 Mitchell Report implicated players associated with both Bay Area teams, and recent years have brought more drug-related suspensions, most recently the bombshells that sidelined Cabrera and Colon in the middle of highly influential seasons.

Tim Kawakami:

It keeps happening, and most specifically, it keeps happening in the Bay Area, home of two baseball teams and a seemingly endless amount of PED use … The Bay Area is the Hometown of Steroids …
Of course, it starts with the whole sordid history of BALCO (the Bay Area Laboratory Co-Operative) and Barry Bonds and the early steroid adventures of Jose Canseco and Mark McGwire. The Mitchell Report was littered with the names of Bay Area players; now, years later, the Bay Area is home to three players testing positive for PED use.

I don’t begrudge a writer using a framing device. But this particular framing device — BALCO, Bonds, Canseco, etc. — is highly misleading.  It creates the impression that the problem is bigger than it truly is and implies connections where there are none.

The subject of PEDs in sports is rife with overheated and misleading rhetoric. What it lacks is actual factual reporting and constructive commentary and ideas. This kind of thing isn’t helping.

Report: Shohei Ohtani has sprained UCL in pitching elbow

Joe Scarnici/Getty Images
6 Comments

The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.

Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”

Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.

Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.